Synthesis and biological properties of novel sphingosine derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 4, 2005, Pages 1115-1119

  Murakami, Teiichi ^a   Furusawa, Kiyotaka ^a   Tamai, Tadakazu ^b   Yoshikai, Kazuyoshi ^b   Nishikawa, Masazumi ^b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b Maruha Nichiro Holdings Inc   (Japan)

Author keywords

Amino alcohols; Antagonists; EDG S1P receptors; Sphingosine 1 phosphate

Indexed keywords

CALCIUM ION; CELL SURFACE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE DERIVATIVE;

ARTICLE; CALCIUM TRANSPORT; CELL ADHESION; CELL GROWTH; CELL STRAIN HL 60; CONTROLLED STUDY; DIASTEREOISOMER; DRUG ACTIVITY; DRUG MECHANISM; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; NEUTROPHIL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; STEREOCHEMISTRY; VASCULAR SMOOTH MUSCLE;

EID: 16244389650     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.12.010     Document Type: Article

References (47)

1. For reviews, see: Y.A. Hannun, and R.M. Bell Science 243 1989 500 507
2. T. Kolter, and K. Sandhoff Angew. Chem., Int. Ed. 38 1999 1532 1568
3. A.H. Merrill Jr. J. Biol. Chem. 277 2002 25843 25846
4. Y.A. Hannun Science 274 1996 1855 1859
5. Y.A. Hannun Sphingolipid-Mediated Signal Transduction 1997 Chapman & Hall New York
6. Y.A. Hannun, and L.M. Obeid J. Biol. Chem. 277 2002 25847 25850
7. For reviews, see: Y. Yatomi, Y. Ozaki, T. Ohmori, and Y. Igarashi Prostaglandins Other Lipid Mediat. 64 2001 107 122
8. S. Spiegel, and S. Milstien J. Biol. Chem. 277 2002 25851 25854
9. A. Olivera, and S. Spiegel Nature 365 1993 557 560
10. M. Mattie, G. Brooker, and S. Spiegel J. Biol. Chem. 269 1994 3181 3188
11. M.-J. Lee, J.R. Van Brocklyn, S. Thangada, C.H. Liu, A.R. Hand, R. Menzeleev, S. Spiegel, and T. Hla Science 279 1998 1552 1555
12. K. Sato, N. Murata, J. Kon, H. Tomura, H. Nochi, K. Tamoto, M. Osada, H. Ohta, Y. Tokumitsu, M. Ui, and F. Okajima Biochem. Biophys. Res. Commun. 253 1998 253 256
13. Y. Yatomi, S. Yamamura, F. Ruan, and Y. Igarashi J. Biol. Chem. 272 1997 5291 5297
14. S. An, Y. Zheng, and T. Bleu J. Biol. Chem. 275 2000 288 296
15. N. Ancellin, and T. Hla J. Biol. Chem. 274 1999 18997 19002
16. M.J. Lee, S. Thangada, K.P. Claffey, N. Ancellin, C.H. Liu, M. Kluk, M. Volpi, R.I. Sha'afi, and T. Hla Cell 99 1999 301 312
17. O.-H. Lee, Y.-M. Kim, Y.-M. Lee, E.-J. Moon, D.-J. Lee, J.-H. Kim, K.-W. Kim, and Y.-K. Kwon Biochem. Biophys. Res. Commun. 264 1999 743 750
18. For a review: S.G. Payne, S. Milstien, S.E. Barbour, and S. Spiegel Sem. Cell Dev. Biol. 15 2004 467 476
19. For recent studies, see: S. Mandala, R. Hajdu, J. Bergstrom, J. Xie, J. Milligan, R. Thornton, G.-J. Shei, D. Card, C. Keohane, M. Rosenbach, J. Hale, C.L. Lynch, K. Rupprecht, W. Parsons, and H. Rosen Science 296 2002 346 349
20. M. Osada, Y. Yatomi, T. Ohmori, H. Ikeda, and Y. Ozaki Biochem. Biophys. Res. Commun. 299 2002 483 487
21. Y. Koide, T. Hasegawa, A. Takahashi, A. Endo, N. Mochizuki, M. Nakagawa, and A. Nishida J. Med. Chem. 45 2002 4629 4638
22. T. Hakogi, T. Shigenari, S. Katsumura, T. Sano, T. Kohno, and Y. Igarashi Bioorg. Med. Chem. Lett. 13 2003 661 664
23. J. Clemens, M.D. Davis, K.R. Lynch, and T.L. Macdonald Bioorg. Med. Chem. Lett. 13 2003 3401 3404
24. A.L. Parrill, D. Wang, D.L. Bautiska, J.R.V. Brocklyn, Z. Lorincz, D.J. Fischer, D.L. Baker, K. Liliom, S. Spiegel, and G. Tigyi J. Biol. Chem. 275 2000 39379 39384
25. H.-S. Lim, Y.-S. Oh, P.-G. Suh, and S.-K. Chung Bioorg. Med. Chem. Lett. 13 2003 237 240
26. H.-S. Lim, J.-J. Park, K. Ko, M.-H. Lee, and S.-K. Chung Bioorg. Med. Chem. Lett. 14 2004 2499 2503
27. 2+ concentration is increased
28. T. Murakami, and K. Furusawa Tetrahedron 58 2002 9257 9263
29. For a review, see: X. Liang, J. Andersch, and M. Bols J. Chem., Soc. Perkin Trans. 1 2001 2136 2157
30. For a review, see: P. Wipf, and H. Jahn Tetrahedron 52 1996 12853 12909
31. Z.M. Szulc, Y.A. Hannun, and A. Bielawska Tetrahedron Lett. 41 2000 7821 7824
32. F. Ruan, Y. Sadahira, S. Hakomori, and Y. Igarashi Bioorg. Med. Chem. Lett. 2 1992 973 978
33. B. Kratzer, and R.R. Schmidt Liebigs Ann. 1995 957 963
34. A. Boumendjel, and S.P.F. Miller J. Lipid Res. 35 1994 2305 2311
35. S. Li, W.K. Wilson, and G.J. Schroepfer Jr. J. Lipid Res. 40 1999 117 125
36. + 274.0774, found 274.0790
37. 2+) and 380 nm (for unreacted Fura-2) at intervals of 0.5 ms, and fluorescence intensity at 510 nm was measured
38. 50 (50% inhibition concentration) value was determined from at least two independent experiments
39. 5P: C, 43.73; H, 5.71; N, 5.67. Found: C, 43.64; H, 5.67; N, 5.48
40. 2: C, 33.63; H, 4.23; N, 3.92; S, 8.98; Br, 44.75. Found: C, 34.29; H, 4.09; N, 3.91; S, 8.91; Br, 44.62
41. M.J. Kluk, and T. Hla Circulation Res. 89 2001 496 502
42. 2 for use in experiments
43. H.G. Gratzner Science 218 1982 474 475
44. L. Allison, D.J. Arndt-Jovin, H. Gratzner, T. Ternynck, and M. Robert-Nicoud Cytometry 6 1985 584
45. A pseudo-blood vessel in vitro inflammation model was constructed as follows: Transwells consisting of two compartments separated by porous membrane were used. A single layer of bovine endothelial cells was cultured on the membrane at the bottom surface of the transwell upper compartment. A suspension of fluorescence-labeled neutrophils was added to the upper compartment, and natural S-1P was suspended in the lower compartment to an end concentration of 10 μM. That is, the upper compartment corresponds to the interior of the blood vessel, while the lower one corresponds to the site of inflammation outside the blood vessel. Fluorescence intensities at 530 nm were measured to determine the number of the neutrophils passing through the endothelial layer and that adhering to it
46. H. Okamoto, N. Takuwa, T. Yokomizo, N. Sugimoto, S. Sakurada, H. Shigematsu, and Y. Takuwa Mol. Cell. Biol. 20 2000 9247 9261
47. Y. Takuwa, H. Okamoto, N. Takuwa, K. Gonda, N. Sugimoto, and S. Sakurada Mol. Cell. Endocrinol. 177 2001 3 11 and references cited therein